- Home
- SRAD vs BRKR Comparison
SRAD vs BRKR Comparison
Compare SRAD & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SRAD | BRKR |
|---|---|---|
| Founded | 2001 | 1960 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 7.0B |
| IPO Year | 2021 | 2000 |
Fundamental Metrics
Financial Performance| Metric | SRAD | BRKR |
|---|---|---|
| Price | $22.96 | $45.46 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 12 |
| Target Price | $30.33 | ★ $46.45 |
| AVG Volume (30 Days) | 1.8M | ★ 2.4M |
| Earning Date | 11-05-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 0.44% |
| EPS Growth | ★ 62.54 | N/A |
| EPS | ★ 0.35 | N/A |
| Revenue | $1,440,977,356.00 | ★ $3,438,900,000.00 |
| Revenue This Year | $18.93 | $3.61 |
| Revenue Next Year | $22.11 | $1.23 |
| P/E Ratio | $66.53 | ★ N/A |
| Revenue Growth | ★ 16.74 | 6.10 |
| 52 Week Low | $16.28 | $28.53 |
| 52 Week High | $32.22 | $64.64 |
Technical Indicators
Market Signals| Indicator | SRAD | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 48.75 | 52.88 |
| Support Level | $22.70 | $44.96 |
| Resistance Level | $23.68 | $47.90 |
| Average True Range (ATR) | 0.71 | 1.85 |
| MACD | 0.27 | -0.58 |
| Stochastic Oscillator | 67.51 | 14.67 |
Price Performance
Historical ComparisonAbout SRAD Sportradar Group AG
Sportradar Group AG is a technology platform enabling next-generation engagement in sports, and a provider of B2B solutions to the sports betting industry. It generates revenue through two primary sources: subscription-based revenue and revenue sharing. Geographically, it operates in North America, Africa, AsiaPac & Middle East, Europe, and LATAM & Caribbean.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.